🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 hora
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 05/09/2007 | 0,3626 USD |
| 06/06/2007 | 0,3626 USD |
| 07/03/2007 | 0,3626 USD |
| 06/12/2006 | 0,3626 USD |
| 30/08/2006 | 0,3626 USD |
| 31/05/2006 | 0,3626 USD |
| 08/03/2006 | 0,3626 USD |
| 30/11/2005 | 0,3626 USD |
| 31/08/2005 | 0,3626 USD |
| 01/06/2005 | 0,3626 USD |
| 02/03/2005 | 0,3626 USD |
| 01/12/2004 | 0,3626 USD |
| 01/09/2004 | 0,3626 USD |
| 02/06/2004 | 0,3531 USD |
| 03/03/2004 | 0,3531 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 10/05/2002 | 53,23 | 54,36 | 52,84 | 53,06 | -0,27% | 2,85% | 6.027.886 |
| 09/05/2002 | 53,34 | 53,80 | 53,21 | 53,21 | -1,54% | 1,11% | 4.820.590 |
| 08/05/2002 | 52,72 | 54,36 | 52,29 | 54,04 | +1,94% | 3,93% | 5.606.695 |
| 07/05/2002 | 53,36 | 53,50 | 52,50 | 53,01 | -0,57% | 1,88% | 6.955.890 |
| 06/05/2002 | 53,05 | 53,72 | 52,97 | 53,31 | +0,67% | 1,42% | 6.422.039 |
| 03/05/2002 | 53,29 | 53,33 | 52,48 | 52,96 | -0,13% | 1,59% | 5.123.462 |
| 02/05/2002 | 52,77 | 53,24 | 52,19 | 53,02 | +0,49% | 1,99% | 7.489.951 |
| 01/05/2002 | 51,57 | 52,96 | 51,54 | 52,77 | +1,77% | 2,76% | 6.713.593 |
| 30/04/2002 | 52,00 | 52,19 | 51,29 | 51,85 | -0,60% | 1,72% | 7.758.030 |
| 29/04/2002 | 51,98 | 52,60 | 51,72 | 52,17 | +0,37% | 1,69% | 6.807.494 |
| 26/04/2002 | 52,58 | 52,58 | 51,31 | 51,98 | -0,77% | 2,41% | 4.980.306 |
| 25/04/2002 | 52,33 | 53,15 | 52,09 | 52,38 | +0,09% | 2,02% | 7.434.722 |
| 24/04/2002 | 52,77 | 53,14 | 52,10 | 52,33 | -1,17% | 1,97% | 6.776.787 |
| 23/04/2002 | 54,01 | 54,34 | 52,73 | 52,95 | -1,82% | 2,99% | 7.531.242 |
| 22/04/2002 | 54,34 | 54,38 | 53,67 | 53,93 | -0,74% | 1,30% | 5.781.816 |
| 19/04/2002 | 54,52 | 54,52 | 54,21 | 54,33 | +0,65% | 0,58% | 8.296.911 |
| 18/04/2002 | 53,44 | 54,15 | 53,24 | 53,98 | +2,76% | 1,70% | 10.308.966 |
| 17/04/2002 | 52,86 | 52,88 | 52,39 | 52,53 | +0,05% | 0,94% | 7.918.374 |
| 16/04/2002 | 52,43 | 52,74 | 52,05 | 52,50 | +0,90% | 1,31% | 7.640.863 |
| 15/04/2002 | 52,00 | 52,45 | 51,60 | 52,03 | +0,98% | 1,63% | 7.270.081 |
| 12/04/2002 | 50,18 | 51,72 | 49,62 | 51,53 | +3,55% | 4,18% | 11.284.235 |
| 11/04/2002 | 50,57 | 51,05 | 48,66 | 49,76 | -1,86% | 4,72% | 14.588.474 |
| 10/04/2002 | 51,29 | 51,33 | 50,48 | 50,71 | -0,84% | 1,66% | 11.391.865 |
| 09/04/2002 | 51,57 | 52,39 | 51,10 | 51,14 | -1,05% | 2,50% | 11.641.079 |
| 08/04/2002 | 52,56 | 52,96 | 51,53 | 51,68 | -1,97% | 2,72% | 9.804.774 |
| 05/04/2002 | 53,52 | 53,55 | 52,49 | 52,72 | -0,99% | 1,98% | 7.930.635 |
| 04/04/2002 | 53,58 | 53,67 | 52,72 | 53,24 | -2,60% | 1,78% | 14.351.731 |
| 03/04/2002 | 55,03 | 55,10 | 54,34 | 54,67 | -0,26% | 1,37% | 7.152.286 |
| 02/04/2002 | 54,96 | 55,11 | 54,20 | 54,81 | -0,28% | 1,65% | 7.415.962 |
| 01/04/2002 | 54,99 | 55,15 | 54,64 | 54,96 | +0,03% | 0,94% | 7.897.204 |